在使用奥马利祖马布的慢性疹患者中,Fcepsilon受体-1α和β (FCER1A和FCER1B) 基因多态性之间的关系
Hulya Savas1, Hatice Uce Ozkol2, Gokhan Gorgisen3
1Department of Dermatology, Erzincan State Hospital, Erzincan, Turkey.
Postepy dermatologii i alergologii
|September 18, 2024
概括
在FCER1A和FCER1B中的遗传变异似乎不会导致慢性疹患者对奥马利祖马布的耐药性. 需要进一步的大规模研究来证实这些发现,以治疗慢性自发性疹.
科学领域:
- 免疫遗传学 免疫遗传学
- 药物基因组学 药物基因组学
- 皮肤病学 皮肤病学
背景情况:
- 慢性 (CU) 管理通常涉及生物疗法奥马利祖马布 (omalizumab).
- 一部分CU患者对奥马利祖马布表现出耐药性,需要对潜在机制进行调查.
- 遗传因素,特别是免疫相关基因中的单核酸多态 (SNP),是治疗耐药性的潜在贡献者.
研究的目的:
- 调查FCER1A和FCER1B中的特定基因多态化与慢性疹患者对奥马利祖马布的耐药性之间的关联.
- 确定潜在的遗传标记,预测该患者群体的奥马利祖马布治疗反应或耐药性.
主要方法:
- 一项病例控制研究,涉及100名耐奥马利祖马布的慢性病患者和50名健康对照.
- 使用实时PCR与光标记探针进行FCER1A (rs2251746) 和FCER1B (rs569108) 多态的基因定型.
- 对SNP基因型分析的生物信息分析,以评估多态和临床特征之间的关系,包括治疗耐药性.
主要成果:
- 在慢性疹患者中,没有发现FCER1A (rs2251746) 或FCER1B (rs569108) 基因多态和奥马利祖马布耐药性之间的统计学意义上的关联.
- 对于FCER1A rs2251746多态的TT和CT基因型之间观察到平均年龄的统计学上显著差异 (p < 0.05).
- 这些特定基因多态化与患者的人口或临床特征之间没有发现相关性.
结论:
- 研究的FCER1A和FCER1B基因多态性不太可能是慢性疹症中奥马利祖马布耐药性的主要决定因素.
- 需要进一步的研究,包括大规模的多中心研究,以探索其他影响奥马利祖马布反应的遗传和非遗传因素.
- 这些发现有助于了解慢性疹症中奥马利祖马布耐药性的复杂机制.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
245
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
245
01:26Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
00:42Cross-reactivity
31.0K
Overview
31.0K
01:39Epistasis
46.5K
In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
46.5K